Article info

PDF

The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder

Authors

  1. Correspondence to Dr Kim Boesen, Nordic Cochrane Centre, Rigshospitalet, Dept. 7811, Blegdamsvej 9, Copenhagen DK-2100, Denmark; kb{at}cochrane.dk

Citation

Boesen K, Saiz LC, Erviti J, et al
The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder

Publication history

  • Accepted 26 June 2017
  • Published in print 1 August 2017.
  • Published online 26 July 2017.
  • Published first 13 July 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.